Paul Saladino· MD
What do you think about a secondary analysis looking at fasting insulin levels in this cohort to address the question: Does metabolic health/dysfunction predict plaque progression?
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
What do you think about a secondary analysis looking at fasting insulin levels in this cohort to address the question: Does metabolic health/dysfunction predict plaque progression?
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
i mean the nmr lipo profile is actually less less valuable than it's made out to be your particle size maybe but in order in some semblance of order of importance i would start with fasting insulin
i would start with fasting insulin because then you're going to know if you're metabolically healthy and you could also triangulate that with a continuous glucose monitor and look at your postprandial levels